ExeVir logo

ExeVir jobs and careers

Zwijnaarde, Belgium

About ExeVir

Rapid viral control in a world that needs it. ExeVir develops single-domain antibody-based therapies that help patients ward off viral infections. Our lead drug candidate is in accelerated development as a COVID-19 therapeutic.

Founded in 2020 by Nico Callewaert and Xavier Saelens.

Founded
2020
Employees
1 to 10
Total funding
$68.6M
Headquarters
Zwijnaarde

Leadership

The top of ExeVir's org chart, with how many people report into each leader.

TMPhoto of Torsten Mummenbrauer

Torsten Mummenbrauer

CEO

5 reports

VBPhoto of Viki Bockstal

Viki Bockstal

Chief Scientific Officer

2 reports

FMPhoto of Fiona Du Monceau

Fiona Du Monceau

COO

CSPhoto of Caroline Sagaert

Caroline Sagaert

COO

Board

EWPhoto of Erica Whittaker

Erica Whittaker

Board Member

MKPhoto of Michel Kazatchkine

Michel Kazatchkine

Board Member

CTPhoto of Caroline Thielen

Caroline Thielen

Board Member

KRPhoto of Katja Rosenkranz

Katja Rosenkranz

Board Observer

JBPhoto of Jérôme Van Biervliet

Jérôme Van Biervliet

Board Member

JHPhoto of Joël Henneghien

Joël Henneghien

Board Observer